Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

TIANYIN PHARMACEUTICAL CO., INC. (TPI)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-14Jun-30-13Jun-30-12Jun-30-11Jun-30-10Jun-30-09Jun-30-08Jun-30-07
   10-K10-K10-K10-K10-K10-K10-K/A10-K
Revenues  46.667.569.695.263.942.933.520.2
            Revenue growth  -31.0%-3.0%-26.9%48.9%49.1%28.2%65.6% 
Cost of goods sold  30.741.545.352.730.621.518.812.3
Gross profit  15.926.024.342.533.321.414.77.9
            Gross margin  34.1%38.5%35.0%44.6%52.2%49.8%43.8%39.2%
Selling, general and administrative   [+]12.315.814.923.417.711.36.91.8
Research and development  0.90.90.91.10.90.30.20.1
Other operating expenses         1.0
EBITDA   [+]5.311.79.819.315.710.47.95.3
            EBITDA margin  11.3%17.4%14.0%20.2%24.6%24.2%23.7%26.3%
Depreciation  1.81.60.50.51.00.70.40.3
EBITA  3.510.19.218.714.79.77.65.0
            EBITA margin  7.5%15.0%13.3%19.7%23.1%22.7%22.6%24.8%
Amortization of intangibles  0.80.80.70.6    
EBIT   [+]2.79.38.518.114.79.77.65.0
            EBIT margin  5.8%13.8%12.3%19.0%23.1%22.7%22.6%24.8%
Non-recurring items         -1.2
Interest expense, net   [+]0.20.30.10.00.0-0.30.4 
Other income (expense), net   [+]-3.1 0.21.6-0.2-0.4  
Pre-tax income  -0.69.08.619.714.59.57.24.8
Income taxes  0.22.42.44.12.61.61.20.8
            Tax rate   26.8%27.5%20.8%18.1%17.2%17.1%17.5%
Minority interest  -0.2-0.1-0.10.00.0   
Net income  -0.66.76.415.511.97.96.03.9
            Net margin  -1.4%9.9%9.1%16.3%18.6%18.4%17.8%19.5%
   
Basic EPS   [+]($0.02)$0.23$0.22$0.55$0.49$0.50$0.00$0.31
Diluted EPS   [+]($0.02)$0.23$0.22$0.52$0.40$0.32$0.00$0.31
   
Dividends per share   [+]   $0.01    
   
Shares outstanding (basic)   [+]29.429.329.328.424.415.914.512.7
Shares outstanding (diluted)   [+]29.429.329.329.730.124.819.112.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy